• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人脑胶质瘤:诊断、治疗和监测指南。

Gliomas in adults: Guidance on investigations, diagnosis, treatment and surveillance.

机构信息

Barts Health NHS Trust, United Kingdom.

Barts Health NHS Trust, United Kingdom.

出版信息

Clin Med (Lond). 2024 Sep;24(5):100240. doi: 10.1016/j.clinme.2024.100240. Epub 2024 Sep 2.

DOI:10.1016/j.clinme.2024.100240
PMID:39233205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11418107/
Abstract

Primary brain tumours are rare but carry a significant morbidity and mortality burden. Malignant gliomas are the most common subtype and their incidence is increasing within our ageing population. The diagnosis and treatment of gliomas involves substantial interplay between multiple specialties, including general medical physicians, radiologists, pathologists, surgeons, oncologists and allied health professionals. At any point along this pathway, patients can present to acute medicine with complications of their cancer or anti-cancer therapy. Increasing the awareness of malignant gliomas among general physicians is paramount to delivering prompt radiological and histopathological diagnoses, facilitating access to earlier and individualised treatment options and allows for effective recognition and management of anticipated complications. This article discusses evidence-based real-world practice for malignant gliomas, encompassing patient presentation, diagnostic pathways, treatments and their complications, and prognosis to guide management outside of specialist centres.

摘要

原发性脑肿瘤较为罕见,但具有显著的发病率和死亡率负担。恶性神经胶质瘤是最常见的亚型,在我们的老龄化人口中其发病率正在增加。神经胶质瘤的诊断和治疗涉及多个专业之间的大量相互作用,包括普通内科医生、放射科医生、病理学家、外科医生、肿瘤学家和相关的医疗保健专业人员。在这条途径的任何一个环节,患者都可能因癌症或抗癌治疗的并发症而到急症医学就诊。提高普通内科医生对恶性神经胶质瘤的认识对于及时进行放射学和组织病理学诊断至关重要,有助于获得更早和个体化的治疗选择,并能够有效识别和处理预期的并发症。本文讨论了恶性神经胶质瘤的循证实际做法,包括患者就诊、诊断途径、治疗及其并发症和预后,以指导在专科中心之外的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/c687432780a4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/d1661ab13b99/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/8f465325e6e9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/8376c5e4bffc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/c687432780a4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/d1661ab13b99/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/8f465325e6e9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/8376c5e4bffc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b5/11418107/c687432780a4/gr4.jpg

相似文献

1
Gliomas in adults: Guidance on investigations, diagnosis, treatment and surveillance.成人脑胶质瘤:诊断、治疗和监测指南。
Clin Med (Lond). 2024 Sep;24(5):100240. doi: 10.1016/j.clinme.2024.100240. Epub 2024 Sep 2.
2
Recognition and management of gliomas.胶质瘤的识别与管理
Drugs. 1997 Feb;53(2):235-44. doi: 10.2165/00003495-199753020-00004.
3
The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.临床因素和癌症干细胞相关标志物在胶质瘤中的预后价值。
Dan Med J. 2014 Oct;61(10):B4944.
4
Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersociety (SINch/AINO/SIN) document.意大利关于低级别胶质瘤的诊断和治疗的共识和建议。一份学会间(SINch/AINO/SIN)文件。
J Neurosurg Sci. 2020 Aug;64(4):313-334. doi: 10.23736/S0390-5616.20.04982-6. Epub 2020 Apr 29.
5
Central nervous system gliomas.中枢神经系统胶质瘤
Crit Rev Oncol Hematol. 2017 May;113:213-234. doi: 10.1016/j.critrevonc.2017.03.021. Epub 2017 Mar 22.
6
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.小儿脑胶质瘤:诊断、生物学和临床管理的最新概念。
J Clin Oncol. 2017 Jul 20;35(21):2370-2377. doi: 10.1200/JCO.2017.73.0242. Epub 2017 Jun 22.
7
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.EANO 指南:间变性神经胶质瘤和胶质母细胞瘤的诊断和治疗。
Lancet Oncol. 2014 Aug;15(9):e395-403. doi: 10.1016/S1470-2045(14)70011-7.
8
Functional nanoparticles in targeting glioma diagnosis and therapies.用于胶质瘤诊断和治疗的功能性纳米颗粒。
J Nanosci Nanotechnol. 2014 Jan;14(1):415-32. doi: 10.1166/jnn.2014.8757.
9
Contemporary management of high-grade gliomas.高级别胶质瘤的当代管理
CNS Oncol. 2018 Jan;7(1):51-65. doi: 10.2217/cns-2017-0026. Epub 2017 Dec 15.
10
The management of incidental low-grade gliomas using magnetic resonance imaging: systematic review and optimal treatment paradigm.利用磁共振成像管理偶发性低级别胶质瘤:系统评价和最佳治疗模式。
Neurosurg Focus. 2011 Dec;31(6):E12. doi: 10.3171/2011.9.FOCUS11219.

引用本文的文献

1
A Phase 0 Window of Opportunity Trial of LB100, a Protein Phosphatase 2A Inhibitor, in Patients with Recurrent Gliomas.蛋白磷酸酶2A抑制剂LB100用于复发性胶质瘤患者的0期机会窗试验
medRxiv. 2025 Aug 21:2025.08.18.25333496. doi: 10.1101/2025.08.18.25333496.
2
Nanoparticles for Glioblastoma Treatment.用于治疗胶质母细胞瘤的纳米颗粒
Pharmaceutics. 2025 May 23;17(6):688. doi: 10.3390/pharmaceutics17060688.
3
Glioblastoma Patient and Caregiver Perspectives of Treatment Side-Effects and Information Provision.胶质母细胞瘤患者及护理人员对治疗副作用和信息提供的看法。

本文引用的文献

1
Antiepileptic Strategies for Patients with Primary and Metastatic Brain Tumors.原发性和转移性脑肿瘤患者的抗癫痫策略。
Curr Treat Options Oncol. 2024 Mar;25(3):389-403. doi: 10.1007/s11864-024-01182-8. Epub 2024 Feb 14.
2
Immunotherapy: a promising approach for glioma treatment.免疫疗法:胶质母细胞瘤治疗的一种有前途的方法。
Front Immunol. 2023 Sep 7;14:1255611. doi: 10.3389/fimmu.2023.1255611. eCollection 2023.
3
IDH-mutant grade 4 astrocytoma: a comparison integrating the clinical, pathological, and survival features between primary and secondary patients.
J Patient Exp. 2025 Apr 10;12:23743735251331770. doi: 10.1177/23743735251331770. eCollection 2025.
4
Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions.胶质母细胞瘤的治疗靶点:分子途径、新兴策略及未来方向
Cells. 2025 Mar 26;14(7):494. doi: 10.3390/cells14070494.
5
Mutations in the , , , and Genes and Their Relationship with Resistance to Temozolomide in Patients with High-Grade Gliomas.高级别胶质瘤患者中 、 、 和 基因的突变及其与替莫唑胺耐药性的关系
Biomedicines. 2024 Dec 6;12(12):2777. doi: 10.3390/biomedicines12122777.
IDH 突变型 4 级星形细胞瘤:原发性和继发性患者临床、病理和生存特征的综合比较。
J Neurosurg. 2023 Jun 30;140(1):94-103. doi: 10.3171/2023.5.JNS222658. Print 2024 Jan 1.
4
DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open.胶质母细胞瘤患者使用DCVax-L疫苗:是真正带来希望还是试验结果不佳?争论已经展开。
Cancers (Basel). 2023 Jun 20;15(12):3251. doi: 10.3390/cancers15123251.
5
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.沃拉西尼布治疗 IDH1 或 IDH2 突变型低级别胶质瘤。
N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4.
6
Molecular Profiling in Neuro-Oncology: Where We Are, Where We're Heading, and How We Ensure Everyone Can Come Along.神经肿瘤学中的分子谱分析:我们身在何处,我们将去往何方,以及我们如何确保每个人都能参与其中。
Am Soc Clin Oncol Educ Book. 2023 May;43:e389322. doi: 10.1200/EDBK_389322.
7
Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option.溶瘤免疫病毒疗法治疗高级别胶质瘤:一种新型且不断发展的治疗选择。
Front Immunol. 2023 Mar 15;14:1118246. doi: 10.3389/fimmu.2023.1118246. eCollection 2023.
8
CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression.胶质母细胞瘤中的嵌合抗原受体T细胞疗法:克服与抗原表达相关的挑战
Cancers (Basel). 2023 Feb 23;15(5):1414. doi: 10.3390/cancers15051414.
9
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.成人脑胶质瘤和其他原发性脑恶性肿瘤:综述。
JAMA. 2023 Feb 21;329(7):574-587. doi: 10.1001/jama.2023.0023.
10
Risk factors and prognostic implications of surgery-related strokes following resection of high-grade glioma.高级别胶质瘤切除术后与手术相关的卒中的风险因素和预后意义。
Sci Rep. 2022 Dec 30;12(1):22594. doi: 10.1038/s41598-022-27127-5.